Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPIRE: Intranasal Insulin for the Prevention of Delirium in ICU Patients
NCT07532577Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2026
- Primary completion
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Generex Oral-lyn in delirium, sponsored by Radboud University Medical Center. Started Apr 2026; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
delirium
Beyond the preview
Go deeper on NCT07532577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07532577.